article · World Journal of Advanced Research and Reviews
Pleural involvement revealing chronic lymphocytic leukemia (CLL) is a rare phenomenon. CLL is a hematologic malignancy characterized by an excessive proliferation of B lymphocytes. Although CLL typically presents with symptoms such as fatigue, frequent infections, and lymphadenopathy, in some cases, it may initially manifest with pleural involvement. This involvement can present as a pleural effusion, leading to symptoms such as dyspnea, chest pain, and a dry cough. Diagnosis relies on cytological analysis of pleural fluid, biopsy, and additional tests such as immunophenotyping. Management includes treatment of the underlying CLL, often with a combination of chemotherapy and immunotherapy. We report the case of a 53-year-old male, a former farmer and chronic smoker, who presented with stage III dyspnea (according to Sadoul), dry cough, and right-sided lower thoracic pain. These symptoms were associated with a general decline in his health status. Clinical examination revealed signs of right-sided pleural effusion, multiple lymphadenopathies (cervical, axillary, inguinal), and hepatosplenomegaly. Laboratory tests showed significant lymphocytosis. A pleural puncture revealed a lymphocytic exudative fluid, and pleural biopsy showed granulomatous inflammation without caseous necrosis. Immunohistochemistry highlighted an abnormal population of B lymphocytes expressing CD19, CD5, CD20, CD23 markers, and a monoclonal population with a predominance of the kappa light chain, thus confirming the diagnosis of chronic lymphocytic leukemia. After confirmation of the stage C CLL diagnosis, the patient was treated with chemotherapy (CHOP protocol).
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.30574/wjarr.2024.24.3.3703
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.